Does Tufts Health Plan Cover Viagra?

How Tufts Health Plan Formularies Work

Tufts Health Plan organizes covered drugs into a tiered formulary. Generic drugs usually sit on Tier 1 or Tier 2, branded drugs with generic alternatives typically land on Tier 3 or Tier 4, and specialty or lifestyle medications may be excluded entirely or placed on the highest cost-sharing tier. Generic sildenafil, which the FDA approved as a first generic in December 2017, is available from multiple manufacturers and costs substantially less than brand-name Viagra.

Formulary Tiers and Cost-Sharing

Each tier carries a different copay or coinsurance rate. A Tier 1 generic might cost $5, $15 per 30-day supply, while a Tier 3 preferred brand could cost $40, $75, and a Tier 4 non-preferred brand could exceed $100 even with insurance. Tufts publishes its current formulary on its member portal and updates it quarterly. Checking the specific plan document, called the Summary of Benefits and Coverage, tells you exactly which tier applies to sildenafil or Viagra on your plan.

Prior Authorization Requirements

Prior authorization (PA) is a process where your insurer reviews a prescription before agreeing to cover it. Brand-name Viagra triggers PA on most commercial Tufts plans because a lower-cost generic alternative exists. Generic sildenafil prescribed for erectile dysfunction may also require PA on some plan variants, particularly high-deductible health plans or Medicaid-managed plans. Your prescribing clinician submits a PA request with a clinical rationale, a diagnosis code (ICD-10 N52.x for erectile dysfunction), and sometimes documentation that other treatments were considered.

Step Therapy Policies

Some Tufts plans use step therapy, meaning the plan requires you to try a preferred drug first. For ED medications, that preferred drug is almost always generic sildenafil. If sildenafil is ineffective or not tolerated, your clinician can document that and request authorization for tadalafil (Cialis generic), vardenafil (Levitra generic), or avanafil (Stendra). The American Urological Association (AUA) 2018 guideline on erectile dysfunction states that all approved PDE5 inhibitors have comparable overall efficacy, which means step therapy to the cheapest generic is clinically defensible [1].

The Clinical Case for Sildenafil Coverage

Erectile dysfunction (ED) affects an estimated 30 million men in the United States according to the National Institute of Diabetes and Digestive and Kidney Diseases [2]. ED is not simply a quality-of-life inconvenience. It serves as an independent marker for cardiovascular disease risk. A 2011 meta-analysis published in the Journal of the American College of Cardiology (N=92,757) found that men with ED had a 44% higher risk of cardiovascular events compared with men without ED [3].

PDE5 Inhibitors: Mechanism and Evidence

Sildenafil works by inhibiting PDE5, the enzyme that degrades cyclic guanosine monophosphate (cGMP) in penile smooth muscle. Higher cGMP levels sustain smooth-muscle relaxation and permit erection in response to sexual stimulation. The FDA approved sildenafil (Viagra) in 1998 based on placebo-controlled trials showing that 69% of all attempts at sexual intercourse were successful in the sildenafil group versus 22% in the placebo group [4].

A 2021 Cochrane systematic review of 82 randomized controlled trials (N=more than 18,000 men) confirmed that PDE5 inhibitors produce a clinically meaningful improvement in erectile function scores compared with placebo, with a standardized mean difference of 0.84 (95% CI 0.78 to 0.91) [5]. That evidence base is why most major formularies include at least one PDE5 inhibitor as a covered drug.

When ED Has an Underlying Cause That Strengthens Coverage Claims

If your ED stems from a documented medical condition, such as type 2 diabetes, hypogonadism, or post-prostatectomy nerve damage, coverage arguments become stronger. Diabetes-related ED occurs in 35 to 75% of men with diabetes according to data from the American Diabetes Association [6]. Insurers are more likely to approve sildenafil coverage when the clinical record links the prescription to a specific underlying condition rather than framing it as a lifestyle medication.

The HealthRX clinical team uses the following documentation framework when helping patients request PDE5 inhibitor coverage from plans with restrictive formularies:

1. Confirm ICD-10 diagnosis code N52.9 (male erectile dysfunction, unspecified) or a more specific code such as N52.01 (erectile dysfunction due to arterial insufficiency).
2. Link the ED diagnosis to any comorbidity: diabetes (E11.x), hypertension (I10), hypogonadism (E29.1), or post-prostatectomy status (Z87.39x).
3. Request a 90-day supply prescription to reduce cost per unit.
4. Ask the prescriber to include a brief clinical note explaining why branded Viagra is medically necessary if generic sildenafil caused a documented adverse reaction.

Tufts Health Plan Product Lines and How Coverage Differs

Tufts operates several distinct plan types. Coverage rules differ significantly across them.

Tufts Health Commercial Plans

Commercial fully-insured plans, sold to employers in Massachusetts and surrounding states, follow the Tufts formulary most people recognize. Generic sildenafil appears on most commercial formularies at Tier 2 or Tier 3. A 2023 analysis by the Kaiser Family Foundation found that about 55% of large employer health plans covered at least one ED medication [7]. Tufts commercial plans fall within that majority for generic sildenafil, though benefit administrators at individual employers can elect to exclude it.

Tufts Health Public Plans (Medicaid Managed Care)

Tufts Health Together is a Medicaid managed care plan. Massachusetts Medicaid (MassHealth) historically excluded most ED medications from coverage because federal Medicaid law allows states to exclude drugs used for sexual dysfunction. As of 2025, MassHealth and its managed care partners, including Tufts Health Together, do not routinely cover sildenafil for erectile dysfunction in adult males under the standard Medicaid benefit. Coverage may exist if sildenafil is prescribed for a different FDA-approved indication, specifically pulmonary arterial hypertension (PAH), where it is marketed as Revatio at a 20 mg dose.

Tufts Medicare Preferred (Medicare Advantage)

Medicare Part D plans are prohibited by federal statute from covering drugs used exclusively for sexual dysfunction, citing the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Tufts Medicare Preferred, as a Medicare Advantage plan with a Part D drug benefit, cannot cover sildenafil or tadalafil when prescribed for ED. The exception again is the PAH indication. Patients on Medicare who need sildenafil for ED pay entirely out of pocket or use GoodRx-type discount programs, which can reduce a 30-pill supply of generic sildenafil (20 mg tablets) to under $30 at major pharmacy chains.

Tufts Health Direct (Marketplace Plans)

Marketplace (ACA exchange) plans sold by Tufts follow the commercial formulary in most respects. The ACA does not classify ED medications as essential health benefits, so inclusion depends on the specific plan's drug benefit. Silver and Gold tier marketplace plans from Tufts have historically included generic sildenafil on their formularies, though this can change during annual open enrollment.

How to Verify Your Specific Coverage in Four Steps

Coverage status for a specific drug changes every plan year. The four steps below produce a definitive answer faster than calling general customer service.

Step 1: Pull the Formulary Document

Log into your Tufts member portal at tuftshealthplan.com. Manage to "Prescription Drug Coverage" and download the current formulary PDF for your specific plan. Search for "sildenafil" and "Viagra" separately. Note the tier number and any footnotes indicating PA or quantity limits.

Step 2: Run a Drug Cost Estimate

The member portal includes a drug pricing tool. Enter "sildenafil citrate 50 mg tablet" and your preferred pharmacy to see the exact copay. Run the same search for the 20 mg dose (Revatio generic) if your clinician thinks that dose is appropriate.

Step 3: Call the Pharmacy Benefits Number

The pharmacy benefits phone number is printed on the back of your Tufts ID card. Ask the representative: "Is sildenafil citrate for erectile dysfunction covered on my plan, what tier is it, and is prior authorization required?" Write down the representative's name and the call reference number.

Step 4: Ask Your Clinician to Submit a Prior Authorization

If coverage requires PA, your clinician's office can submit it electronically through CoverMyMeds or directly through the Tufts provider portal. PA decisions are generally returned within 72 hours for non-urgent requests. If denied, you receive a written denial with appeal rights.

What to Do If Tufts Denies Coverage

A denial is not the end of the road. Federal and Massachusetts state law give you the right to appeal.

Internal Appeal

File an internal appeal within 30 days of the denial notice. Attach a letter from your clinician explaining the medical necessity of the medication, relevant lab results (e.g., testosterone level if hypogonadism is contributing), and any peer-reviewed literature supporting the treatment. The AUA Guideline statement that "PDE5 inhibitors are recommended as first-line therapy for erectile dysfunction" [1] can be quoted directly in an appeal letter.

External Appeal

If the internal appeal fails, Massachusetts law requires that Tufts offer an independent external review through a state-certified Independent Review Organization (IRO). The IRO decision is binding on the insurer. External appeals are free for members. The Massachusetts Division of Insurance oversees this process.

Exception Request for Non-Formulary Brand Viagra

If your clinician believes brand Viagra is medically necessary because of a documented intolerance to generic formulations (rare, but possible due to inactive excipient differences), a formulary exception request is the correct pathway. Tufts must respond to exception requests within 72 hours (24 hours for urgent cases) under CMS regulations applicable to all MA-region commercial plans.

Cost Comparison: Covered vs. Out-of-Pocket Options

Even without insurance coverage, generic sildenafil is one of the most affordable branded-to-generic transitions in recent pharmaceutical history. The table below reflects approximate 2025 market pricing.

| Option | Dose | Quantity | Estimated Cost | |---|---|---|---| | Generic sildenafil, Tufts Tier 2 copay | 50 mg | 30 tablets | $10, $40 | | Brand Viagra, Tufts Tier 4 | 50 mg | 30 tablets | $80, $150 | | Generic sildenafil, GoodRx discount | 50 mg | 30 tablets | $15, $35 | | Generic sildenafil, Costco Pharmacy | 50 mg | 30 tablets | $18, $25 | | Generic tadalafil (Cialis generic) | 5 mg daily | 30 tablets | $15, $50 | | Avanafil (Stendra), cash pay | 100 mg | 6 tablets | $150, $200 |

Generic sildenafil became available in the U.S. After Pfizer's exclusivity patents were successfully challenged. The FDA approved the first generic sildenafil in December 2017 [8]. Multiple manufacturers now produce it, keeping prices competitive even without insurance.

The Pulmonary Arterial Hypertension Exception

Sildenafil 20 mg three times daily is FDA-approved under the brand name Revatio for pulmonary arterial hypertension (PAH). This indication carries a separate CMS exemption: Medicare Part D plans can cover sildenafil when it is prescribed for PAH, and Medicaid plans may also cover it for this indication. If a Tufts member has both ED and PAH, the prescription must specify the PAH indication to obtain coverage. Prescribing sildenafil for ED under a PAH diagnosis code when PAH is not present is insurance fraud and carries serious legal consequences.

Telehealth Prescribing and Tufts Coverage

Tufts covers telemedicine visits across most plan types following Massachusetts's telehealth parity law, which requires commercial insurers to reimburse telehealth visits at the same rate as in-person visits for covered services. A clinician at a telehealth practice, including HealthRX, can evaluate erectile dysfunction, confirm the diagnosis, and prescribe generic sildenafil if clinically appropriate. The telehealth visit itself is typically covered as a standard outpatient consultation. The prescription then runs through the same pharmacy benefit rules described above.

The FDA does not restrict clinicians from prescribing sildenafil via telehealth. Prescribers must conduct a clinically adequate evaluation, including a cardiovascular history (sildenafil is contraindicated with nitrate medications due to the risk of severe hypotension) [4], before issuing a prescription regardless of visit modality.

Cardiovascular Safety Considerations That Affect Prescribing

Sildenafil's interaction with nitrates is the most clinically significant contraindication. Coadministration with any organic nitrate, including nitroglycerin, isosorbide mononitrate, or recreational amyl nitrite ("poppers"), can cause a precipitous and potentially fatal drop in blood pressure [4]. The prescribing clinician must screen for nitrate use, which is common in men with angina, before issuing a sildenafil prescription.

The Princeton Consensus Panel (Third Princeton Consensus Conference, 2012) stratified cardiovascular risk for sexual activity and PDE5 inhibitor use into low, intermediate, and high categories [9]. Men at low cardiovascular risk can use PDE5 inhibitors with standard clinical oversight. Men at intermediate or high risk require further cardiac evaluation before a prescription is appropriate. Tufts prior authorization reviewers may request documentation of cardiovascular clearance for patients over age 65 or those with known coronary artery disease.

A 2014 study in the Journal of the American Medical Association (N=1,519 post-myocardial infarction patients) found no significant increase in recurrent cardiac events in men who used PDE5 inhibitors after MI, suggesting that appropriately selected patients can use sildenafil safely [10]. That evidence supports coverage decisions in medically supervised contexts.

Hypogonadism, Testosterone, and ED: An Often-Missed Coverage Angle

Low testosterone contributes to ED in a meaningful subset of men. The Endocrine Society clinical practice guideline recommends measuring morning serum total testosterone in men presenting with sexual dysfunction [11]. If testosterone is below the laboratory reference range (generally <300 ng/dL in most U.S. Labs), testosterone replacement therapy (TRT) may restore erectile function independently or may improve the response to sildenafil.

Tufts Health Plan covers TRT for documented hypogonadism. If a Tufts member's ED is driven by low testosterone, addressing the hormonal root cause through covered TRT may reduce or eliminate the need for sildenafil, sidestepping the formulary coverage question entirely. A clinician at HealthRX can order the relevant labs, interpret results in clinical context, and design a treatment plan that optimizes what your Tufts plan already covers.

The Endocrine Society guideline specifies: "We recommend measuring fasting morning testosterone levels (before 10 a.m.) on two separate occasions before diagnosing hypogonadism" [11]. That two-measurement standard matters for insurance coverage of TRT as well.

Generic Sildenafil vs. Brand Viagra: Is There a Clinical Difference?

FDA bioequivalence standards require that a generic drug deliver between 80% and 125% of the active ingredient's exposure compared to the reference brand, with a 90% confidence interval within that range. Generic sildenafil meets these standards. Multiple bioequivalence studies submitted to the FDA during the approval process confirmed comparable pharmacokinetic profiles [8].

Clinically, the active molecule is identical. Some patients report subjective differences in response, which may be related to inactive excipients affecting tablet disintegration or individual absorption variability. No randomized head-to-head trial has demonstrated a statistically significant difference in erectile function scores between brand Viagra and FDA-approved generic sildenafil. Requesting brand Viagra based on clinical preference alone is unlikely to satisfy a Tufts PA reviewer's medical necessity standard.